A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer’s disease

Hugo Geerts, Patrick Roberts, Athan Spiros, Robert Carr
  • Frontiers in Pharmacology, January 2013, Frontiers Media SA
  • DOI: 10.3389/fphar.2013.00047

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.3389/fphar.2013.00047

The following have contributed to this page: Hugo Geerts